These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1675 related articles for article (PubMed ID: 19758662)

  • 1. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
    Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
    Lughezzani G; Jeldres C; Isbarn H; Sun M; Shariat SF; Alasker A; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Eur J Cancer; 2009 Dec; 45(18):3291-7. PubMed ID: 19615885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.
    Lughezzani G; Sun M; Perrotte P; Shariat SF; Jeldres C; Budäus L; Latour M; Widmer H; Duclos A; Bénard F; McCormack M; Montorsi F; Karakiewicz PI
    Urology; 2010 Feb; 75(2):321-7. PubMed ID: 19962727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly predictive survival nomogram after upper urinary tract urothelial carcinoma.
    Jeldres C; Sun M; Lughezzani G; Isbarn H; Shariat SF; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Cancer; 2010 Aug; 116(16):3774-84. PubMed ID: 20564085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Roscigno M; Shariat SF; Margulis V; Karakiewicz P; Remzi M; Kikuchi E; Langner C; Lotan Y; Weizer A; Bensalah K; Raman JD; Bolenz C; Guo CC; Wood CG; Zigeuner R; Wheat J; Kabbani W; Koppie TM; Ng CK; Suardi N; Bertini R; Fernández MI; Mikami S; Isida M; Michel MS; Montorsi F
    J Urol; 2009 Jun; 181(6):2482-9. PubMed ID: 19371878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival.
    Park J; Ha SH; Min GE; Song C; Hong B; Hong JH; Kim CS; Ahn H
    J Urol; 2009 Sep; 182(3):894-9. PubMed ID: 19616243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system.
    Holmäng S; Johansson SL
    Urology; 2005 Aug; 66(2):274-8. PubMed ID: 16098355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter.
    Jeldres C; Lughezzani G; Sun M; Isbarn H; Shariat SF; Budaus L; Lattouf JB; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2010 Apr; 183(4):1324-9. PubMed ID: 20171666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma.
    Jeldres C; Sun M; Isbarn H; Lughezzani G; Budäus L; Alasker A; Shariat SF; Lattouf JB; Widmer H; Pharand D; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Feb; 75(2):315-20. PubMed ID: 19963237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract.
    Hong B; Park S; Hong JH; Kim CS; Ro JY; Ahn H
    Urology; 2005 Apr; 65(4):692-6. PubMed ID: 15833510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?
    Maulard-Durdux C; Dufour B; Hennequin C; Chrétien Y; Vignes B; Droz D; Delanian S; Housset M
    J Urol; 1996 Jan; 155(1):115-7. PubMed ID: 7490805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma.
    Akdogan B; Dogan HS; Eskicorapci SY; Sahin A; Erkan I; Ozen H
    J Urol; 2006 Jul; 176(1):48-52. PubMed ID: 16753365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma.
    Lughezzani G; Jeldres C; Isbarn H; Shariat SF; Sun M; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Jan; 75(1):118-24. PubMed ID: 19864000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma.
    Wu CF; Pang ST; Chen CS; Chuang CK; Chen Y; Lin PY
    J Urol; 2007 Aug; 178(2):446-50, dicussion 450. PubMed ID: 17561129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
    Kim DS; Lee YH; Cho KS; Cho NH; Chung BH; Hong SJ
    Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors impacting survival in patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy.
    Mouracade P; Velten M; Gigante M; Alenda O; Ploussard G; Obadia F; Timsit MO; Mejean A
    Can J Urol; 2012 Feb; 19(1):6105-10. PubMed ID: 22316512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urothelial carcinoma of the upper urinary tract. Survival and prognostic factors].
    Arrizabalaga Moreno M; Díez Rodríguez JM; García González JI; Esteban Arteaga R; Navarro Sebastián J; Castro Pita M; Mora Durban M; Paniagua Andrés P
    Arch Esp Urol; 1998 Apr; 51(3):243-51. PubMed ID: 9622915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer.
    Akao J; Matsuyama H; Yamamoto Y; Hara T; Kawai Y; Sakano S; Ohmi C; Gondo T; Naito K
    BJU Int; 2008 Aug; 102(5):572-5. PubMed ID: 18485032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases.
    Capitanio U; Shariat SF; Isbarn H; Weizer A; Remzi M; Roscigno M; Kikuchi E; Raman JD; Bolenz C; Bensalah K; Koppie TM; Kassouf W; Fernández MI; Ströbel P; Wheat J; Zigeuner R; Langner C; Waldert M; Oya M; Guo CC; Ng C; Montorsi F; Wood CG; Margulis V; Karakiewicz PI
    Eur Urol; 2009 Jul; 56(1):1-9. PubMed ID: 19361911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.